Work

Inhibition of the mammalian target of rapamycin (mTOR) as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies - A review of the evidence

Year: 2026
Type: article
Abstract: mTOR inhibition shows antiepileptogenic effects in tuberous sclerosis mouse models and limited clinical data; evidence remains preclinical and not definitive.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7235393679
FWCI:
Cites:
Cited by:
Related to: 10